Of all the copper-binding peptides studied in oxidative-stress research, GHK-Cu sits in a unique position: it is a molecule the human body already produces — declining sharply from roughly 200 ng/mL in healthy young adults to below 80 ng/mL in aged plasma (Pickart & Margolina 2018) — and yet it continues to surprise investigators with the breadth of biological pathways it touches. Most research teams coming to GHK-Cu are initially attracted by the wound-healing literature. They stay because of the antioxidant and genomic data. This review unpacks the peer-reviewed mechanism work so research teams sourcing ghk-cu in stock UAE can evaluate the scientific basis before designing protocols. All vials referenced below are stocked and dispatched by REVIVE LAB UAE — ghk-cu Dubai 24h delivery, HPLC-verified, lot-COA documented.
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. The peptide backbone — three amino acids: glycine, histidine, lysine — was first isolated from human albumin by Loren Pickart in 1973. Its high-affinity Cu2+ binding (Ka ~1015 M-1) distinguishes it from loosely chelated copper species that can participate in Fenton-type radical generation. By binding copper in a stable, redox-buffered complex, GHK-Cu delivers the metal ion in a biologically active but non-toxic configuration — a distinction that matters enormously in oxidative-stress research, where "free" copper is itself a pro-oxidant.
| Property | Value / Detail |
|---|---|
| Full chemical name | Glycyl-L-histidyl-L-lysine copper(II) complex |
| Molecular weight | ~340 Da (peptide) + Cu coordination |
| Natural source | Human plasma, saliva, urine; albumin-derived |
| Plasma concentration (young adult) | ~200 ng/mL (Pickart & Margolina 2018) |
| Plasma concentration (aged adult) | <80 ng/mL — roughly 60% decline |
| Cu2+ binding affinity | Ka ~1015 M-1 (high-affinity chelation) |
| Primary research focus | Antioxidant signalling, DNA repair, wound healing, skin remodelling |
| REVIVE LAB UAE vials stocked | GHK-Cu 50mg, GHK-Cu 100mg |
The age-related decline in circulating GHK-Cu is what makes investigators treat it as a potential research tool for studying oxidative stress models in aged tissue systems. Pickart and Margolina (2018) document this trajectory and connect the declining plasma GHK-Cu gradient to parallel declines in tissue-repair capacity, suggesting GHK-Cu is a physiological regulator rather than a passive byproduct.
The antioxidant activity of GHK-Cu is not a single mechanism but a layered response spanning enzyme induction, transcription-factor activation, and lipid-peroxidation suppression. Pickart and Margolina's 2018 Cosmetics review — the most comprehensive mechanistic summary available in the peer-reviewed literature — identifies three primary antioxidant axes.
The nuclear factor erythroid 2-related factor 2 (Nrf2) is the master regulator of the cellular antioxidant response. Under baseline conditions Nrf2 is held in the cytoplasm by its inhibitor protein Keap1. Oxidative or electrophilic stress causes Keap1 to release Nrf2, which translocates to the nucleus and binds antioxidant response elements (AREs), driving transcription of phase-II detoxifying enzymes — heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), glutathione S-transferases, and the catalytic subunit of glutamate-cysteine ligase (GCLC), the rate-limiting enzyme in glutathione synthesis.
Pickart and Margolina (2018) document GHK-Cu as an activator of this pathway, with HO-1 upregulation being the most consistently reported downstream effect. HO-1 degrades pro-oxidant heme into biliverdin, carbon monoxide (CO), and free iron — all of which carry independent cytoprotective signalling roles. The net result is a shift in cellular redox balance toward antioxidant defence without requiring exogenous scavengers.
Beyond Nrf2-driven transcription, GHK-Cu has been reported to increase activity of superoxide dismutase (SOD) — the enzyme that converts superoxide radicals (O2•−) to hydrogen peroxide — and catalase, which then neutralises H2O2 to water and oxygen. This enzymatic cascade is the cell's first-line defence against mitochondria-generated reactive oxygen species (ROS). Critically, the copper delivered via the GHK-Cu complex may serve as a cofactor for Cu/Zn-SOD, providing substrate-level support rather than merely transcriptional induction (Pickart & Margolina 2018).
Lipid peroxidation — the oxidative degradation of polyunsaturated fatty acids in cell membranes — is a hallmark of chronic oxidative stress and a key pathological event in aged tissue. Pickart and Margolina (2018) review evidence that GHK-Cu inhibits iron-induced lipid peroxidation in model systems, consistent with its high-affinity copper chelation preventing Fenton-type reactions. Parallel anti-inflammatory effects are documented across more than 30 inflammation-related genes, including downregulation of TNF-α and a suite of pro-inflammatory interleukins — reducing the oxidative micro-environment in which ROS-driven damage propagates.
| Antioxidant Axis | Mechanism | Key Downstream Effect | Primary Source |
|---|---|---|---|
| Nrf2/ARE activation | Nrf2 nuclear translocation, ARE binding | HO-1, NQO1, GCLC upregulation; glutathione synthesis | Pickart & Margolina 2018 |
| SOD / Catalase induction | Enzyme activity increase; Cu cofactor supply | O2•− → H2O2 → H2O neutralisation | Pickart & Margolina 2018 |
| Lipid peroxidation inhibition | High-affinity Cu chelation blocks Fenton reaction | Reduced membrane lipid oxidation | Pickart & Margolina 2018 |
| DNA-repair gene modulation | 84-gene upregulation in human fibroblasts | Genomic integrity maintenance under oxidative load | Campbell et al. 2012 |
| Anti-inflammatory gene suppression | TNF-α, IL-6, NF-κB pathway modulation | Reduced ROS-driving inflammatory micro-environment | Pickart & Margolina 2018 |
The antioxidant literature on GHK-Cu took a significant turn with Campbell et al.'s 2012 BMC Genomics analysis. The investigators applied whole-genome microarray profiling to human fibroblasts exposed to GHK-Cu and identified modulation of over 4,000 genes — with a particularly striking cluster in DNA-damage recognition and repair pathways.
The key finding: GHK-Cu upregulated 84 genes associated with DNA-repair processes, including nucleotide excision repair (NER), base excision repair (BER), and double-strand break response pathways. This is not a trivial footnote. DNA damage is both a cause and a consequence of oxidative stress — ROS attack guanine bases (producing 8-oxoguanine) and cause strand breaks that, if unrepaired, propagate mutation and senescence. A molecule that simultaneously suppresses ROS generation and upregulates the machinery for clearing oxidative DNA lesions addresses both sides of the equation.
Campbell et al. (2012) also noted GHK-Cu's effects on genes governing cell adhesion, migration, and extracellular matrix remodelling — results consistent with the wound-healing literature, but suggesting that the antioxidant and tissue-remodelling phenotypes may share a common genomic upstream.
For investigators designing oxidative-stress or ageing research protocols and sourcing GHK-Cu UAE, the Campbell dataset is arguably the most important primary reference: it places GHK-Cu firmly in the genomic-antioxidant category, not merely the scavenging category.
The wound-healing body of evidence for GHK-Cu predates the antioxidant genomics work and remains the most clinically translated corner of the literature. Pickart's 2008 Advances in Wound Care review synthesises decades of in vitro and in vivo data across skin, bone, and soft tissue repair models.
The core wound-healing mechanisms identified in this body of work are:
The connection to antioxidant biology is direct: wound environments are characterised by high local ROS, generated by neutrophils and activated macrophages during the inflammatory phase. GHK-Cu's dual ability to suppress that ROS load (via Nrf2 and SOD induction) while simultaneously driving fibroblast-mediated repair (Pickart 2008) makes it a mechanistically coherent research molecule for oxidative injury models.
One characteristic noted across multiple GHK-Cu studies is a biphasic or inverted-U concentration-response, with optimal biological effects typically observed at nanomolar to low-micromolar concentrations in cell-culture systems. Investigators planning research protocols should consult the primary literature for model-specific concentration ranges — the 50mg and 100mg vials stocked by REVIVE LAB UAE provide sufficient material for extended in vitro series at these concentrations.
| Research Area | Key Finding | Reference |
|---|---|---|
| Antioxidant signalling | Nrf2/ARE activation, HO-1 upregulation, SOD/catalase increase, lipid peroxidation inhibition | Pickart & Margolina 2018 |
| Genomic antioxidant defence | 84 DNA-repair genes upregulated in human fibroblasts; 4,000+ total gene modulations identified | Campbell et al. 2012 |
| Wound healing | Collagen synthesis, fibroblast activation, VEGF-driven angiogenesis, decorin induction | Pickart 2008 |
| Anti-inflammatory | TNF-α downregulation, 30+ pro-inflammatory gene suppression, NF-κB pathway modulation | Pickart & Margolina 2018 |
REVIVE LAB UAE stocks two vial sizes for research-context use. Both are lyophilised powder, sterile-manufactured, and dispatched with lot-specific certificate of analysis (COA) confirming HPLC purity. Investigators should refer to their own institutional reconstitution protocols and the relevant literature for solvent selection — GHK-Cu is water-soluble and typically reconstituted in sterile water or PBS for in vitro work.
| Vial Size | Form | Typical In Vitro Use | COA Available |
|---|---|---|---|
| GHK-Cu 50mg | Lyophilised powder | Multiple cell-culture series, concentration-response panels | Yes — lot-specific HPLC |
| GHK-Cu 100mg | Lyophilised powder | Extended protocols, multi-timepoint studies, larger-volume assays | Yes — lot-specific HPLC |
Storage: lyophilised GHK-Cu vials should be kept at 2-8°C, protected from light and moisture. Once reconstituted, use within the timeframe recommended by your protocol — do not expose reconstituted solutions to repeated freeze-thaw cycles. REVIVE LAB UAE dispatches all GHK-Cu in validated cold-chain insulation, ensuring the vial arrives at the stated specification regardless of UAE ambient temperatures.
The short answer for researchers in the UAE: REVIVE LAB UAE is the only locally-stocked, HPLC-verified source for ghk-cu in stock UAE with cold-chain courier dispatch and a documented COA. Ordering from offshore suppliers introduces cold-chain unknowns, customs delays, and purity ambiguity — all of which are eliminated when the stock is held and dispatched within the UAE.
| Emirate / Area | Delivery Window | Cash on Delivery | Cold Chain |
|---|---|---|---|
| Dubai (Marina, JBR, DIFC, Downtown, Business Bay, Palm, JVC) | Same-day, 4-8 hours | Yes | Yes |
| Abu Dhabi (Corniche, Yas, Saadiyat, Reem Island) | Next-day, 18-24 hours | Yes | Yes |
| Sharjah | Same-day / next-day, 8-18 hours | Yes | Yes |
| Ajman, Ras Al Khaimah, Umm Al Quwain | Next-day, 18-24 hours | Yes | Yes |
| Fujairah, Al Ain | Next-day, up to 24 hours | Yes | Yes |
Payment options include cash on delivery (cash on delivery Dubai and all other emirates), bank transfer, and — for the USDT TRC20 route — a 5% pre-pay discount when settling via USDT crypto pay Dubai through Binance Pay. Researchers preferring a discreet, plain outer carton will find that unbranded packaging is the default across all orders.
REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched GHK-Cu across all 7 emirates, alongside the broader peptides UAE catalogue including Retatrutide, Tesamorelin, BPC-157, TB-500, Semax, and NAD+. For the full list, see the GHK-Cu UAE product page or browse the main catalogue.
REVIVE LAB UAE stocks GHK-Cu 50mg and 100mg vials with same-day dispatch in Dubai (orders placed before the daily cut-off) and ghk-cu Dubai 24h delivery to all other emirates including Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, UAQ, and Al Ain. All vials are HPLC-verified with lot-specific COA. Cash on delivery is accepted across the UAE, and USDT TRC20 crypto pay is available via Binance Pay (5% pre-pay discount applies).
REVIVE LAB UAE currently stocks GHK-Cu in two research vial sizes: 50mg and 100mg. Both are lyophilised powder with lot-specific HPLC certificate of analysis (COA). No other vial sizes are available at this time. Investigators requiring specific concentrations should plan reconstitution volumes accordingly.
Peer-reviewed research — principally Pickart and Margolina (Cosmetics, 2018) and Campbell et al. (BMC Genomics, 2012) — documents three primary antioxidant mechanisms: (1) activation of the Nrf2/ARE transcription pathway, driving upregulation of heme oxygenase-1, NQO1, and glutathione-synthesis enzymes; (2) upregulation of superoxide dismutase and catalase activity, neutralising mitochondria-derived reactive oxygen species; and (3) modulation of 84 DNA-repair associated genes in human fibroblasts, supporting genomic integrity under oxidative load. Lipid-peroxidation suppression and downregulation of TNF-α and related pro-inflammatory genes are additionally documented by Pickart and Margolina (2018).